Avalanche Biotechnologies Inc (ADVM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

800 SAGINAW DRIVE REDWOOD CITY, CA 94063

Avalanche Biotechnologies Inc. develops gene therapies for the treatment of ophthalmologic disorders. The Company creates therapeutic protein for treatments of eye disease. Avalanche operates in the United States.

Data as of 2020-07-04
Market Cap1.672 Billion Shares Outstanding80.296 Million Avg 30-day Volume1.25 Million
P/E Ratio Dividend Yield EPS-1.09
Price/Sales6687.01 Price cash flow ratio242.9 Price free cash flow ratio-29.8
Book Value3.79 Price to Tangible Book5.57 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.116848
BETA2.20301 52-week High/Low26.98 / 4.96 Stddev0.274448
View SEC Filings from ADVM instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 7 2 (0.13%)
13F Filers holding this stock: 126 42 (2.75%)
Aggregate 13F shares on 03/31/2020: 79.829 Million 42.751 Million
Aggregate 13F shares on 12/31/2019: 60.147 Million 28.709 Million
Percent change: 32.72% 48.91%
Funds creating new positions: 33 16
Funds Adding to an existing position: 51 16
Funds closing out their position: 19 9
Funds reducing their position: 31 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ADVM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADVM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

68.2 Thousand total shares from 12 transactions

Exercise Derivative Conversion (M)

55 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PATTERSON LEONE D

  • Director
0 2020-07-09 9

GASMI MEHDI

  • Director
0 2020-06-23 11

WOIWODE THOMAS

  • Director
0 2020-06-23 2

MACHADO PATRICK

  • Director
0 2020-06-23 3

CARTER ERIC G

  • Director
0 2020-06-23 2

HEMRAJANI REKHA

  • Director
0 2020-06-23 3

SCOPA JAMES PAUL

  • Director
0 2020-06-23 5

LUPHER, JR. MARK L.

  • Director
0 2020-06-23 3

WHITCUP SCOTT M

  • Director
0 2020-06-23 3

FISCHER LAURENT CEO AND DIRECTOR

  • Officer
  • Director
0 2020-06-15 2

BAIN LINDA

  • Director
0 2020-06-10 0

SWARTZBURG MICHAEL VP, FINANCE

  • Officer
0 2020-06-10 0

COUNTOURIOTIS ATHENA

  • Director
0 2020-06-08 0

HULL HANS CHIEF BUSINESS OFFICER

  • Officer
149,037 2020-06-05 0

MCLAUGHLIN JOHN PETER

  • Director
86,974 2020-05-18 0

BLUMENKRANZ MARK S.

  • Director
0 2020-05-14 0

SALZMAN AMBER

  • Director
0 2020-04-13 0

THEDINGA ANGELA CHIEF TECHNOLOGY OFFICER

  • Officer
0 2020-02-21 2

OSBORNE AARON CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-20 1

LEUNG THOMAS CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-20 1

SOPARKAR PETER CHIEF LEGAL OFFICER

  • Officer
0 2020-02-20 3

GUERIN JOHN PATRICK ET AL

  • Director
  • 10% Owner
173,513 2020-01-02 0

CLEVELAND PAUL B

  • Director
0 2019-10-22 0

FINER MITCHELL H.

  • Director
0 2019-07-31 2

SPIVEY RICHARD N.

  • Director
0 2019-07-31 1

CHENG JENNIFER C. GENERAL COUNSEL

  • Officer
0 2019-02-14 0

WACHTER PAUL

0 2018-06-14 0

SCHWARTZ STEVEN DANIEL

  • Director
398,991 2017-06-12 0

BARONE SAMUEL B. SVP, CLINICAL DEVELOPMENT

  • Officer
172,335 2017-02-09 0

RUSSO CARLO EVP AND CHIEF MEDICAL OFFICER

  • Officer
0 2016-05-11 0

VERSANT VENTURES IV, LLC

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT IV LUXCO S.A R.L.

VERSANT CAPITAL IV (SWITZERLAND) GMBH

  • 10% Owner
7,003,892 2016-05-11 0

RUBIO ROMAN G. SVP, TRANSLATIONAL MEDICINE

  • Officer
165,650 2016-02-12 0

BRAUN SHIRLEY VP, HUMAN RESOURCES

  • Officer
161,140 2016-02-12 0

CHALBERG THOMAS W. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,099,401 2015-06-10 0

ZYGTECH, LLC

  • 10% Owner
No longer subject to file 2015-04-13 0

REGENERON PHARMACEUTICALS INC

  • 10% Owner
No longer subject to file 2014-08-05 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
No longer subject to file 2014-08-05 0

VENROCK ASSOCIATES VI, L.P.

VENROCK PARTNERS VI, L.P.

VENROCK MANAGEMENT VI, LLC

VENROCK PARTNERS MANAGEMENT VI, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

HOVE ANDERS D

KOH BONG Y

  • 10% Owner
2,365,471 2014-08-05 0

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP MANAGEMENT II, LLC

  • 10% Owner
2,365,471 2014-08-05 0

VENROCK ASSOCIATES VI, L.P.

VENROCK PARTNERS VI, L.P.

VENROCK MANAGEMENT VI, LLC

VENROCK PARTNERS MANAGEMENT VI, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

ROBERTS BRYAN E

HOVE ANDERS D

  • 10% Owner
0 2014-07-30 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
0 2014-07-30 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SCOPA JAMES PAUL - Director

2020-06-23 A 30,000 a 30,000 0.00 direct

WHITCUP SCOTT M - Director

2020-06-23 A 30,000 a 30,000 0.00 direct

WOIWODE THOMAS - Director

2020-06-23 A 30,000 a 30,000 0.00 direct

GASMI MEHDI - Director

2020-06-23 A 30,000 a 30,000 0.00 direct

CARTER ERIC G - Director

2020-06-23 A 30,000 a 30,000 0.00 direct

MACHADO PATRICK - Director

2020-06-23 A 30,000 a 30,000 0.00 direct

LUPHER, JR. MARK L. - Director

2020-06-23 A 30,000 a 30,000 0.00 direct

HEMRAJANI REKHA - Director

2020-06-23 A 30,000 a 30,000 0.00 direct

GASMI MEHDI - Director

2020-06-22 M 23,605 d 83,000 274,442.00 direct

GASMI MEHDI - Director

2020-06-22 S 23,605 $25.06 d 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-06-22 M 23,605 $4.80 a 298,047 274,442.00 direct

GASMI MEHDI - Director

2020-06-18 M 11,127 d 106,605 274,442.00 direct

GASMI MEHDI - Director

2020-06-18 M 11,127 $4.80 a 285,569 274,442.00 direct

GASMI MEHDI - Director

2020-06-18 S 11,127 $25.01 d 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-06-17 M 268 d 117,732 274,442.00 direct

GASMI MEHDI - Director

2020-06-17 S 268 $25.01 d 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-06-17 M 268 $4.80 a 274,710 274,442.00 direct

PATTERSON LEONE D - Officer PRESIDENT

2020-06-16 S 13,171 $24.68 d 110,488 110,488.00 direct

GASMI MEHDI - Director

2020-06-15 M 10,000 d 118,000 274,442.00 direct

GASMI MEHDI - Director

2020-06-15 S 1,416 $21.93 d 278,026 274,442.00 direct

GASMI MEHDI - Director

2020-06-15 S 159 $23.59 d 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-06-15 S 5,000 $21.01 d 279,442 274,442.00 direct

FISCHER LAURENT - Director - Officer CEO AND DIRECTOR

2020-06-15 A 1,200,000 a 1,200,000 0.00 direct

GASMI MEHDI - Director

2020-06-15 S 3,425 $23.00 d 274,601 274,442.00 direct

GASMI MEHDI - Director

2020-06-15 M 10,000 $4.80 a 284,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-21 S 3,599 $20.02 a 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-21 M 3,599 d 128,000 274,442.00 direct

GASMI MEHDI - Director

2020-05-21 M 3,599 $4.80 a 278,041 274,442.00 direct

GASMI MEHDI - Director

2020-05-20 M 1,401 d 131,599 274,442.00 direct

GASMI MEHDI - Director

2020-05-20 S 1,401 $20.01 d 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-20 M 1,401 $4.80 a 275,843 274,442.00 direct

GASMI MEHDI - Director

2020-05-18 M 5,000 $4.80 a 279,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-18 S 300 $19.03 d 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-18 S 4,700 $18.11 d 274,742 274,442.00 direct

GASMI MEHDI - Director

2020-05-18 M 5,000 d 133,000 274,442.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments